Medicare Enrolled

Dr. Christopher Adams, M.D.

Rheumatology · Pensacola, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5190 BAYOU BLVD STE 2, Pensacola, FL 32503
8507460560
In practice since 2006 (19 years)
NPI: 1720039175 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Adams from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adams? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Adams

Dr. Christopher Adams is a rheumatology specialist in Pensacola, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Adams performed 25,167 Medicare services across 986 unique beneficiaries.

Between the years covered by Open Payments, Dr. Adams received a total of $19,812 from 47 pharmaceutical and/or device companies across 1110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Adams is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in FL $19,812 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 176921 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
25,167
Medicare services
Top 42% in FL for rheumatology
986
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,325 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria) 10,703 $10 $50
Abatacept infusion (Orencia) 8,350 $34 $100
Denosumab injection (Prolia/Xgeva) 3,960 $18 $31
Steroid injection (triamcinolone) 551 $1 $5
Office visit, established patient (30-39 min) 469 $80 $250
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 205 $46 $130
Drug injection, under skin or into muscle 194 $11 $45
Administration of chemotherapy into vein, 1 hour or less 161 $90 $265
Office visit, established patient, complex (40-54 min) 105 $114 $340
Administration of chemotherapy into vein, each additional hour 88 $20 $75
Injection of additional new drug or substance into vein 77 $11 $35
Injection, methylprednisolone sodium succinate, up to 125 mg 59 $4 $20
Joint injection, major joint 57 $48 $120
Office visit, established patient (20-29 min) 43 $61 $175
X-ray of hand, minimum of 3 views 39 $26 $66
New patient office visit, complex (60-74 min) 39 $144 $420
Injection of trigger points, 1-2 muscles 35 $31 $100
Aspiration and/or injection of fluid from small joint 17 $35 $100
X-ray of lower and sacral spine, minimum of 4 views 15 $34 $95
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
76.5% high complexity
20.7% medium
2.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,812
Total received (2018-2024)
Avg $2,830/year across 7 years
Top 23% in FL for rheumatology
47
Companies
1,110
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,743 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,949
2023
$3,759
2022
$3,150
2021
$2,032
2020
$1,500
2019
$2,464
2018
$2,958

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,258
UCB, Inc.
$2,102
Janssen Biotech, Inc.
$1,454
AbbVie Inc.
$1,366
PFIZER INC.
$1,222
GlaxoSmithKline, LLC.
$1,029
ABBVIE INC.
$997
E.R. Squibb & Sons, L.L.C.
$893
Mallinckrodt Hospital Products Inc.
$857
Lilly USA, LLC
$725
Radius Health, Inc.
$665
Novartis Pharmaceuticals Corporation
$587
AstraZeneca Pharmaceuticals LP
$504
Horizon Therapeutics plc
$466
AbbVie, Inc.
$356
Aurinia Pharma U.S., Inc.
$335
Genentech USA, Inc.
$314
Regeneron Healthcare Solutions, Inc.
$309
ANI Pharmaceuticals, Inc.
$307
Exeltis, USA Inc.
$277
Alexion Pharmaceuticals, Inc.
$246
Horizon Pharma plc
$212
Antares Pharma, Inc.
$150
Sobi, Inc
$127
Celgene Corporation
$123
Mallinckrodt LLC
$105
Mallinckrodt Enterprises LLC
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Hikma Pharmaceuticals USA
$55
GENZYME CORPORATION
$54
CSL Behring
$53
MEDEXUS PHARMA, INC.
$52
MEDAC PHARMA, INC.
$52
SOBI, INC
$45
Kyowa Kirin, Inc.
$44
TerSera Therapeutics LLC
$43
West-Ward Pharmaceuticals
$38
Fresenius Kabi USA, LLC
$38
Organon Llc
$37
Kiniksa Pharmaceuticals International, plc
$25
Ultragenyx Pharmaceutical Inc.
$24
Actelion Pharmaceuticals US, Inc.
$20
Pharming Healthcare, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Johnson & Johnson Health Care Systems Inc.
$15
Kiniksa Pharmaceuticals, Ltd.
$13
Janssen Scientific Affairs, LLC
$9
Top 3 companies account for 34.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · Haegarda · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $79 per 100 Medicare services performed
Looking for a rheumatology specialist in Pensacola?
Compare rheumatologists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
14
Per 100K population
4.3
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Adams is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Adams experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Adams performed 10,703 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Adams receive payments from pharmaceutical companies?
Yes. Dr. Adams received a total of $19,812 from 47 companies across 1,110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adams's costs compare to other rheumatologists in Pensacola?
Dr. Adams's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adams) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →